• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前常用抗真菌药物的不良反应:网状Meta分析与系统评价

Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review.

作者信息

Yang Yan-Li, Xiang Zi-Jian, Yang Jing-Hua, Wang Wen-Jie, Xu Zhi-Chun, Xiang Ruo-Lan

机构信息

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Beijing Zhiyun Data Technology Co., Ltd., Beijing, China.

出版信息

Front Pharmacol. 2021 Oct 29;12:697330. doi: 10.3389/fphar.2021.697330. eCollection 2021.

DOI:10.3389/fphar.2021.697330
PMID:34776941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8585744/
Abstract

Invasive fungal infections (IFI) is an important contributing factor in morbidity and mortality of immunocompromised and critically ill patients. Although the therapeutic effects of these drugs on IFI have been well documented, the long-term use of antifungal agents has raised concerns about drug tolerability and treatment-related toxicity risks. We searched articles published before June 30, 2020 in four electronic databases: Web of Science, Cochrane Library, embase and PubMed. 66 trials were determined to meet our inclusion criteria, providing data on 18,230 participants. We sorted out 23 AEs by system organ classes and six laboratory AEs, 13 of these were used to construct 13 network meta-analyses. Compared with LAmB, anidulafungin, caspofungin, micafungin, fluconazole, and posaconazole had a significantly low incidence of discontinuation of therapy due to AEs (OR = 0.24 (0.09,0.65), 0.24 (0.13,0.43), 0.32 (0.19,0.52), 0.38 (0.23,0.62) and 0.35 (0.17,0.69), respectively). We found that echinocandins are the most tolerated antifungal agents with high safety. The AEs of triazole drugs are mainly concentrated on the increase in liver enzymes, nervous system disorders, especially visual disorders, gastrointestinal disorders, and cardiac diseases. LAmB is the least tolerated and has the most abundant AEs.

摘要

侵袭性真菌感染(IFI)是免疫功能低下和危重症患者发病和死亡的重要因素。尽管这些药物对IFI的治疗效果已有充分记录,但抗真菌药物的长期使用引发了对药物耐受性和治疗相关毒性风险的担忧。我们检索了截至2020年6月30日在四个电子数据库(Web of Science、Cochrane图书馆、Embase和PubMed)上发表的文章。确定有66项试验符合我们的纳入标准,提供了18230名参与者的数据。我们按系统器官类别梳理出23种不良事件(AE)和6种实验室AE,其中13种用于构建13项网络荟萃分析。与两性霉素B相比,阿尼芬净、卡泊芬净、米卡芬净、氟康唑和泊沙康唑因AE导致治疗中断的发生率显著较低(比值比分别为0.24(0.09,0.65)、0.24(0.13,0.43)、0.32(0.19,0.52)、0.38(0.23,0.62)和0.35(0.17,0.69))。我们发现棘白菌素是耐受性最高且安全性高的抗真菌药物。三唑类药物的AE主要集中在肝酶升高、神经系统紊乱,尤其是视觉障碍、胃肠道紊乱和心脏疾病。两性霉素B耐受性最差且AE最多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a878/8585744/a6a69e4e8fb5/fphar-12-697330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a878/8585744/2aeaf0f93977/fphar-12-697330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a878/8585744/a6a69e4e8fb5/fphar-12-697330-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a878/8585744/2aeaf0f93977/fphar-12-697330-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a878/8585744/a6a69e4e8fb5/fphar-12-697330-g002.jpg

相似文献

1
Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review.当前常用抗真菌药物的不良反应:网状Meta分析与系统评价
Front Pharmacol. 2021 Oct 29;12:697330. doi: 10.3389/fphar.2021.697330. eCollection 2021.
2
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.脂质体两性霉素B:关于其在发热性中性粒细胞减少症经验性治疗及侵袭性真菌感染治疗中应用的综述
Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010.
3
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.棘白菌素类与三唑类药物预防和治疗真菌感染的疗效及安全性:一项随机对照试验的荟萃分析
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):651-9. doi: 10.1007/s10096-014-2287-4. Epub 2014 Dec 14.
4
Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.选择最佳抗真菌药物预防非中性粒细胞减少危重症患者真菌感染:试验序贯分析、网络荟萃分析和药物经济学分析。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00620-17. Print 2017 Dec.
5
Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.新型抗真菌药物米卡芬净和伏立康唑用于造血细胞移植期间预防真菌感染的荟萃分析。
Eur Rev Med Pharmacol Sci. 2016;20(2):381-90.
6
Treatment of invasive candidal infections: systematic review and meta-analysis.侵袭性念珠菌感染的治疗:系统评价与荟萃分析
Mayo Clin Proc. 2008 Sep;83(9):1011-21. doi: 10.4065/83.9.1011.
7
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
8
Newer antifungal agents for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis.造血细胞移植期间预防真菌感染的新型抗真菌药物:一项荟萃分析。
Transplant Proc. 2013 Jan-Feb;45(1):407-14. doi: 10.1016/j.transproceed.2012.07.149.
9
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies.唑类、多烯类和棘白菌素类抗真菌药物预防血液恶性肿瘤患者侵袭性真菌感染的网状 Meta 分析。
BMC Cancer. 2021 Apr 14;21(1):404. doi: 10.1186/s12885-021-07973-8.
10
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.棘白菌素类药物(安尼卡芬净、卡泊芬净和米卡芬净)治疗和预防侵袭性念珠菌病及其对使用和成本的影响:文献复习。
Eur J Med Res. 2011 Apr 28;16(4):180-6. doi: 10.1186/2047-783x-16-4-180.

引用本文的文献

1
Antidermatophytic activity of Curcuma longa against Trichophyton spp.: compound identification and molecular docking to lanosterol 14α-demethylase.姜黄对毛癣菌属的抗皮肤癣菌活性:化合物鉴定及与羊毛甾醇14α-去甲基酶的分子对接
BMC Complement Med Ther. 2025 Sep 1;25(1):321. doi: 10.1186/s12906-025-05049-9.
2
Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects.应对全球抗真菌挑战:医学与农业层面
ACS Bio Med Chem Au. 2025 Jul 2;5(4):531-552. doi: 10.1021/acsbiomedchemau.5c00103. eCollection 2025 Aug 20.
3
Terbinafine Resistance in and : A Literature Review.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature.全身性使用的唑类抗真菌药引起的皮肤过敏:文献综述
Recent Pat Inflamm Allergy Drug Discov. 2019;13(2):144-157. doi: 10.2174/1872213X13666190919162414.
3
A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
特比萘芬在[具体疾病或情况]中的耐药性:文献综述 。(原文中“and”后面应该缺失了具体内容)
Antibiotics (Basel). 2025 May 7;14(5):472. doi: 10.3390/antibiotics14050472.
4
Progress and Prospects of Triazoles in Advanced Therapies for Parasitic Diseases.三唑类药物在寄生虫病先进治疗方法中的进展与前景
Trop Med Infect Dis. 2025 May 20;10(5):142. doi: 10.3390/tropicalmed10050142.
5
Antifungal activity of almond () hull extracts against clinical isolates of .杏仁()壳提取物对临床分离株的抗真菌活性。 你提供的原文中括号部分内容缺失,请补充完整以便更准确翻译。
Curr Med Mycol. 2024 Jan 4;10. doi: 10.22034/cmm.2024.345248.1545. eCollection 2024.
6
Effects of Nisin A Combined with Antifungal Drug Against Growth of Species.乳酸链球菌素A与抗真菌药物联合使用对菌种生长的影响。
Dent J (Basel). 2025 Apr 8;13(4):160. doi: 10.3390/dj13040160.
7
Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance.念珠菌病:对毒力因子、补体逃避和抗真菌药物耐药性的见解。
Microorganisms. 2025 Jan 25;13(2):272. doi: 10.3390/microorganisms13020272.
8
In vivo toxicological evaluation of 3-benzylideneindolin-2-one: antifungal activity against clinical isolates of dermatophytes.3-亚苄基吲哚-2-酮的体内毒理学评价:对皮肤癣菌临床分离株的抗真菌活性
BMC Pharmacol Toxicol. 2025 Jan 23;26(1):16. doi: 10.1186/s40360-025-00850-1.
9
Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study.质子泵抑制剂与泊沙康唑联合预防血液系统恶性肿瘤患者侵袭性真菌感染的有效性:一项回顾性研究。
Int J Clin Pharm. 2025 Apr;47(2):382-391. doi: 10.1007/s11096-024-01841-8. Epub 2024 Dec 7.
10
Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients. An Official American Thoracic Society Clinical Practice Guideline.成人肺部及危重症患者侵袭性肺曲霉病的治疗以及侵袭性念珠菌病的预防和经验性治疗。美国胸科学会官方临床实践指南。
Am J Respir Crit Care Med. 2024 Nov 18;211(1):34-53. doi: 10.1164/rccm.202410-2045ST.
伏立康唑与泼尼松龙单药治疗急性加重期变应性支气管肺曲霉病合并哮喘的随机试验
Eur Respir J. 2018 Sep 18;52(3). doi: 10.1183/13993003.01159-2018. Print 2018 Sep.
4
We can do better: a fresh look at echinocandin dosing.我们可以做得更好:重新审视棘白菌素的给药剂量。
J Antimicrob Chemother. 2018 Mar 1;73(3):831. doi: 10.1093/jac/dky013.
5
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.伊曲康唑与伏立康唑治疗曲霉菌和其他丝状真菌所致侵袭性霉菌病的初步治疗(SECURE):一项 3 期随机对照非劣效性试验。
Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10.
6
Application of caspofungin in China compared with amphotericin B and fluconazole.卡泊芬净在中国的应用与两性霉素 B 和氟康唑的比较。
Ther Clin Risk Manag. 2014 Sep 10;10:737-41. doi: 10.2147/TCRM.S47146. eCollection 2014.
7
A design-by-treatment interaction model for network meta-analysis with random inconsistency effects.一种用于具有随机不一致效应的网络荟萃分析的治疗设计交互模型。
Stat Med. 2014 Sep 20;33(21):3639-54. doi: 10.1002/sim.6188. Epub 2014 Apr 29.
8
Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections.艾沙康唑概况及其在治疗严重侵袭性真菌感染中的潜力。
Infect Drug Resist. 2013 Oct 22;6:163-74. doi: 10.2147/IDR.S51340.
9
Graphical tools for network meta-analysis in STATA.STATA 中的网络荟萃分析图形工具。
PLoS One. 2013 Oct 3;8(10):e76654. doi: 10.1371/journal.pone.0076654. eCollection 2013.
10
Overview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial data.在缺乏直接头对头临床试验数据的情况下比较药物疗效的方法概述。
Br J Clin Pharmacol. 2014 Jan;77(1):116-21. doi: 10.1111/bcp.12150.